Physician profile
Granit Veseli
NPI 1396036091
$24,955.44
in general payments reported to CMS, 2019-2025
30 companies · $1,175 in 2025
The $1,175 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,423 · 2020: $684 · 2021: $3,162 · 2022: $931 · 2023: $4,568 · 2024: $10K · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,598 · Food and Beverage: $6,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,598.21 |
| Food and Beverage | $6,157.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,894.88 | 2021-2025 | Diamondtemp Bidirectional Ablation Catheter, Linq II, Arctic Front Advance |
| Abbott Laboratories | $5,679.57 | 2020-2025 | Aveir, Amplatzer Amulet, Amplatzer Torqvue 45 X 45 |
| Biotronik INC. | $4,070.32 | 2021-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Boston Scientific Corporation | $3,224.75 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Watchman Access System |
| Medtronic Vascular, INC. | $2,178.78 | 2019 | |
| Biosense Webster, INC. | $720.15 | 2019-2025 | Carto 3, Qdot Micro Catheter |
| Cvrx, INC. | $631.16 | 2022-2024 | Barostim Neo System |
| Amgen INC. | $220.60 | 2020-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $186.12 | 2021-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $167.62 | 2020-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.22 | 2023-2025 | Jardiance |
| Philips North America LLC | $112.69 | 2024 | (Ao0) Igt Devices Intracardiac |
| Novo Nordisk INC | $88.91 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Amarin Pharma, INC. | $82.50 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $78.30 | 2021-2024 | Evkeeza |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $73.29 | 2021 | |
| Tactile Systems Technology INC | $51.39 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Irhythm Technologies, INC. | $50.85 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals Lp | $48.07 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $38.97 | 2023-2025 | Verquvo |
| Pfizer INC. | $35.50 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $27.82 | 2020-2021 | |
| Inspire Medical Systems, INC. | $24.54 | 2024 | Inspire |
| Baxter Healthcare | $24.39 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Astellas Pharma US INC | $23.96 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $22.62 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $21.36 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.27 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $18.55 | 2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Granit Veseli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.